On August 18th, during the 18th China Health Industry Summit (SIP Summit), Sinopharm Healthcare Technology officially released the "2025 Healthy China · Brand List". Relying on its solid brand strength, Jiuyue® Loxoprofen Sodium Gel Patch successfully won the "SIP Gold Award" in the external analgesic category — this is also the second time that the Jiuyue® brand has received this honor following 2024.

The selection of the "Healthy China · Brand List" is based on four dimensions: product value, market value, profit expectation and user praise. It conducts a three-dimensional scan and evaluation of brands through the systematic and scientific 4D-BES system, and constructs a brand development index evaluation model with a full quantitative index. Finally, the list is generated based on the evaluation results, which comprehensively reflects the comprehensive competitiveness of the brand.

Jiuyue® Loxoprofen Sodium Gel Patch was approved for marketing in 2017. As an external preparation, it is mainly used for the treatment of osteoarthritis, muscle pain, and swelling, pain and other musculoskeletal diseases caused by trauma. Only five years after its launch, the sales volume of Jiuyue® Loxoprofen Sodium Gel Patch exceeded 1 billion yuan, and the off-hospital sales volume increased by 300% year-on-year in the past three years. At the same time, with the company's continuous promotion of brand building and efforts in various fields such as sports events, online platforms and public welfare activities, the influence of the Jiuyue® brand has been continuously enhanced.

In the future, the company will continue to pursue its brand strategy, continuously improve brand innovation, product quality and market competitiveness, and strive to contribute more solid strength to the development of China's pharmaceutical and health industry and provide patients with higher-quality pharmaceutical products and services.